Your institution may have access to this item. Find your institution then sign in to continue.
Title
Phase II trial of docetaxel and oxaliplatin in patients with advanced gastric cancer and/or adenocarcinoma of the gastroesophageal junction.
Authors
Richards, D; McCollum, D; Wilfong, L; Sborov, M; Boehm, K A; Zhan, F; Asmar, L
Abstract
Platinum-based chemotherapy is the standard treatment for advanced gastric cancer (GC). This trial explored the efficacy and tolerability of combined docetaxel (Taxotere) + oxaliplatin (DOCOX) in GC patients.
Publication
Annals of oncology : official journal of the European Society for Medical Oncology, 2008, Vol 19, Issue 1, p104